UN health R&D summit 'leaves the greater part of the job undone.' MSF's Statement at the close of the UN Health R&D Summit
GAVI and the AMC Will governments make the right decision on May 20th ?
UN talks on R&D system 'leave the greater part of the job undone'
- ©TaunusGrafik
‘Concrete proposals to ensure urgently needed drugs and diagnostics are developed for developing country diseases have not received support. Considering the colossal needs we see in MSF daily practice, this is a lost opportunity,’ said Dr. Tido von Schoen-Angerer, Director of Médecins Sans Frontières (MSF)’s Access Campaign at the close of UN health R&D summit.
Putting Patients First: MSF collection of interviews and essays on some of the gaps in medical research and access and some proposals to reform the current system
Read more about the Intergovernmental Working Group on Public Health, Innovation and Intellectual Property (IGWG)
Stimulating the Debate on Malnutrition
MSF took its malnutrition campaign to a meeting of key actors in the nutritional community held in Vietnam earlier this year. Click here to read more about MSF's activities at the Standing Committee on Nutrition Read about MSF's malnutrition campaign
MSF at the IGWGThursday 1 May Read The Campaign director's address to the IGWG Read MSF's press release calling on governments to put the talk into action Read MSF's submissions to the IGWG Read MSF's report on progress at the IGWG Read MSF's Comments to the European Commission on the WHO draft Global Strategy and Plan of Action on public health, innovation and IP
|
Is the GAVI plan for pneumococcal vaccine too expensive ?
The pneumococcal vaccine could save millions of lives. But the Advance Market Commitment, set up by GAVI to fund it, is far too expensive. Read the Campaign's director, Dr. Tido von Schoen-Angerer, in Development Today. Read more about AMCs and the discussions around the pneumococcal AMC Give us the tools we need
From an effective diagnostic test for TB, to drugs that work against Chagas disease and HIV treatments for children and pregnant women - none of these are available to our teams in the field because of the failure of the current system of medical R&D. Click here to read more about the medical challenges we face and how IGWG could help |
Press releases
Key publications
05 May 2008
Tough Choices: Tenofovir, Tenders and Treatment 
24 April 2008
MSF Comments to EC on WHO IGWG strategy and POA
07 April 2008
Field news
30 April 2008
The Hospital on the Edge of Town: Treating MDR TB in Karakalpakstan
24 April 2008
07 February 2008
